Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
17
WINT Quote, Financials, Valuation and Earnings
Last price:
$0.33
Seasonality move
:
-9.01%
Day range:
$0.32 - $0.34
52-week range:
$0.32 - $14.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.26x
P/B ratio:
0.69x
Volume:
457.9K
Avg. volume:
933.7K
1-year change:
-97.47%
Market cap:
$3M
Revenue:
--
EPS (TTM):
-$16.53
Earnings Data
Next earnings date for WINT
Apr 17
2025
Most recent earnings per share
-$4.23
Missed by $1.96
(Nov 27/2024)
Consensus Estimate
-$2.27
(Nov 27/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
WINT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -- | -$0.92 | -- |
| 11/27/2024 | Q3 | -- | -- | -$4.23 | -$2.27 | -$1.96 |
| 08/19/2024 | Q2 | -- | -- | -$20.91 | -$8.11 | -$12.80 |
| 05/15/2024 | Q1 | -- | -- | $21.98 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$13.37 | -$16.92 | $3.55 |
| 11/09/2023 | Q3 | -- | -- | -$15.48 | -$11.34 | -$4.14 |
| 06/30/2023 | Q2 | -- | -- | -$29.52 | -$12.24 | -$17.28 |
| 03/31/2023 | Q1 | -- | -- | -$85.65 | -$10.08 | -$75.57 |
| 12/31/2022 | Q4 | -- | -- | -$234.18 | -- | -- |
| 11/10/2022 | Q3 | -- | -- | -$117.18 | -$198.00 | $80.82 |
| 08/05/2022 | Q2 | -- | -- | -$534.24 | -$225.00 | -$309.24 |
| 05/13/2022 | Q1 | -- | -- | -$258.48 | -$261.00 | $2.52 |
| 03/29/2022 | Q4 | -- | -- | -$380.52 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$279.00 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$1,278.00 | -- | -- |
| 05/13/2021 | Q1 | -- | -- | -$459.00 | -- | -- |
| 03/15/2021 | Q4 | -- | -- | -$387.00 | -- | -- |
| 11/16/2020 | Q3 | -- | -- | -$486.00 | -- | -- |
| 08/13/2020 | Q2 | -- | -- | -$567.00 | -- | -- |
| 05/13/2020 | Q1 | -- | -- | -$432.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$567.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$594.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$540.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$549.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$1,954.88 | -- | -- |
| 09/30/2018 | Q3 | -- | -- | -$2,808.00 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$2,187.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$3,780.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | $2,069.46 | -- | -- |
| 11/14/2017 | Q3 | -- | -- | -$26,749.13 | -- | -- |
| 08/21/2017 | Q2 | -- | -- | -$37,353.85 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$69,649.72 | -- | -- |
| 03/31/2017 | Q4 | -- | -- | -$41,006.21 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$53,608.97 | -- | -- |
| 08/10/2016 | Q2 | -- | -- | -$69,437.91 | -- | -- |
| 05/12/2016 | Q1 | -- | -- | -$91,453.95 | -- | -- |
| 03/16/2016 | Q4 | -- | -- | -$72,582.78 | -- | -- |
| 11/12/2015 | Q3 | -- | -- | -$145,648.65 | -- | -- |
| 08/11/2015 | Q2 | -- | -- | -$100,230.09 | -- | -- |
| 05/07/2015 | Q1 | -- | -- | -$107,778.76 | -- | -- |
| 03/17/2015 | Q4 | -- | -- | -$110,026.55 | -- | -- |
Windtree Therapeutics Earnings Questions
-
How Much did Windtree Therapeutics Generate in Revenue Last Quarter?
Windtree Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Windtree Therapeutics Beat Earnings Last Quarter?
Windtree Therapeutics announced earnings per share of -$4.23 which represents a miss of analyst forecast a -$2.27 per share.
-
Is Windtree Therapeutics Profitable?
Windtree Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Windtree Therapeutics EPS Next Year?
Windtree Therapeutics's earnings are forecast to decrease from -$94.32 per share to -$94.86 per share next year representing a decrease of -94%.
-
When is Windtree Therapeutics's Earnings Date?
Windtree Therapeutics's next earnings date is April 17, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
